Obinutuzumab activates FcγRI more potently than other anti-CD20 antibodies in chronic lymphocytic leukemia (CLL) by Shlomo Elias, Shira Kahlon, Rebecca Kotzur, Noah Kaynan, Ofer Mandelboim

Get full text

The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors. by Rachel Yamin, Noa S Kaynan, Ariella Glasner, Alon Vitenshtein, Pinchas Tsukerman, Yoav Bauman, Yael Ophir, Shlomo Elias, Yotam Bar-On, Chamutal Gur, Ofer Mandelboim

Get full text

Dupilumab for cancer-associated refractory pruritus by Aviv Talmon, MD, Shlomo Elias, MD, PhD, Limor Rubin, MD, Yaarit Ribak, MD, Eyal Ben Dori, MD, Oded Shamriz, MD, Michal Lotem, MD, Irit Adini, PhD, Yuval Tal, MD, PhD

Get full text